Study Reveals Fluvoxamine's Effectiveness in Treating Long COVID
A new study indicates that the low-cost antidepressant, Fluvoxamine, can reduce chronic fatigue symptoms associated with Long COVID, affecting 65 million people globally.
Latest news and articles about long covid from NEX English
A new study indicates that the low-cost antidepressant, Fluvoxamine, can reduce chronic fatigue symptoms associated with Long COVID, affecting 65 million people globally.